Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-9190 vs Rocuronium for Neuromuscular Blockade During General Anesthesia
NCT07404579Phase 2Completed
- Sponsor
- Hengrui
- Start
- Mar 2026
- Primary completion
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-9190 in neuromuscular blockade (NMB), sponsored by Hengrui. Started Mar 2026; status: completed.
02
Drugs
HRS-9190
03
Conditions
neuromuscular blockade (NMB)
Beyond the preview
Go deeper on NCT07404579.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07404579.